用0.1%他扎罗汀凝胶治疗恶性雀斑样痣。

Treatment of lentigo maligna with tazarotene 0.1% gel.

作者信息

Chimenti Sergio, Carrozzo Anna Maria, Citarella Luigi, De Felice Catia, Peris Ketty

机构信息

Department of Dermatology, University of Rome Tor Vergata, Italy.

出版信息

J Am Acad Dermatol. 2004 Jan;50(1):101-3. doi: 10.1016/j.jaad.2003.07.005.

DOI:10.1016/j.jaad.2003.07.005

PMID:14699375

Abstract

We report 2 elderly patients with facial lentigo maligna who experienced complete regression, both clinically and histopathologically, after once-daily topical treatment with tazarotene 0.1% gel for 6 to 8 months. After a follow-up period of 18 and 30 months, no recurrence was observed. We believe that tazarotene might be considered as an alternative medical approach in selected patients with lentigo maligna.

摘要

我们报告了2例面部恶性雀斑样痣老年患者，在每日外用0.1%他扎罗汀凝胶治疗6至8个月后，临床和组织病理学上均实现了完全消退。经过18个月和30个月的随访期，未观察到复发。我们认为，对于某些面部恶性雀斑样痣患者，他扎罗汀可被视为一种替代医学治疗方法。